fda compounding semaglutide warning letters september 2025 and Novo Nordisk Warned of GLP-1 Telehealth Takedown. What's Next? FDA issues 30 warning letters

As the body stabilizes on treatment, cortisol typically normalizes, and the fatigue associated with it resolves

If the commercial value of the new matter is meaningful only in combination with the original invention a specific dosing titration method for a particular formulation of a specific API claiming them separately in different patent families would produce claims too narrow to enforce without asserting both families

Specifically, beyond the enteroendocrine L-cells of the intestine, GLP-1 is also produced as a neuropeptide by the pre-proglucagon neurons in the brain stem 3

Research has found GLP-1 medications associated with a 45% reduction in Alzheimers disease risk 32